Pharmafile Logo
Pharmafocus logo
Advanced Search
abbvie_0

NICE rejects AbbVie’s leukaemia drug

February 16, 2017
Sales and Marketing AbbVie

NICE has rejected AbbVie Venclyxto (venetoclax) for the treatment of chronic lymphocytic leukmaemia, on various grounds but primarily focusing upon …

News
mosquito

Malaria vaccine displays 100% success rate in clinical trial

February 16, 2017
Research and Development Vaccine, malaria

A malaria vaccine, jointly developed by the University of Tübingen and biotech company Sanaria Inc., has demonstrated in a small pool …

News
facilities_lg06

Dr Reddy’s rocked by negative patent infringement ruling, shares hit one-year low

February 16, 2017
Sales and Marketing Dr Reddy's Laboratories, Helsinn Healthcare

India-based pharmaceutical firm Dr Reddy’s Laboratories has been hit by an unfavourable ruling in a legal case claiming it infringed …

News
lavalbldg1806696_853705

FDA approves Valeant plaque psoriasis drug despite suicide concerns

February 16, 2017
Sales and Marketing FDA, Siliq, Valeant, psoriasis

The US Food and Drug Administration (FDA) has announced that it has approved Valeant Pharmaceutical’s injectable psoriasis treatment Siliq (brodalumab) …

News
handshake-2056023_960_720

Integra bids $1.045 billion for J&J’s neurosurgery business

February 16, 2017
Sales and Marketing Codman, Integra, J&J, JJ, Johnson & Johnson

Integra, a medical technology company, have announced that it has made a binding offer to acquire Johnson & Johnson’s Codman …

News

Woodley Equipment Company Exhibiting at Outsourcing in Clinical Trials West Coast 2017

February 15, 2017
Lab Equipment supplier, Medical Equipment Supplier, medical equipment

The Clinical Trials Team at Woodley Equipment Company is exhibiting at Outsourcing in Clinical Trials West Coast 2017 which is taking place …

News
Press release
shutterstock_159488225

New cancer drug could give hope to non-responsive patients

February 15, 2017
Research and Development Cancer

A new dual action drug developed as part of a collaboration between biopharmaceutical oncology firm Almac Discovery and The Royal …

News

Stada encourages bidding war, with figure of €3.5 billion mooted

February 15, 2017
Research and Development, Sales and Marketing Advent International, Cinven, Stada

Stada, the German generic drugmaker, has received two offers for takeover, with one estimated to be €3.5 billion, thought to …

News
shutterstock_146497481

US panel endorses human embryo gene editing, with caveats

February 15, 2017
Research and Development crispr, gene editing

Gene editing in human embryos has been given the go-ahead by a panel of experts from the US National Academy …

News
merck_entrance

MSD’s Alzheimer’s drug failure undermines potential treatment pathway

February 15, 2017
Research and Development Alzheimer's, MSD, Merck

MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …

News
device_magnetic

Magnetic implant could revolutionise drug delivery

February 15, 2017
Research and Development University of British Colombia, University of British Colombia - Device next to Canadian one dollar coin., magnetic implant

Researchers from the University of British Columbia have invented a new method of drug delivery that relies on magnets to …

News
614px-flexed_plastic_display

Plastic electronics to bring “mind-blowing” developments for pharma

February 14, 2017
Manufacturing and Production, Research and Development plastic electronics

Plastic electronics could be the next big thing for pharma production and treatment , according to a new report on …

News
down_arrow

Hepatitis C market set for slump as cure rates rise

February 14, 2017
Manufacturing and Production, Medical Communications, Sales and Marketing Gilead, hepatitis C

Objectively, it is the pharmaceutical industries intention to find cures for diseases and to aid patients to live a full …

News
gsk_boronia_australia

GSK unveils strong showing for twin-drug HIV treatment

February 14, 2017
Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay

GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …

News
marathon_logo

Marathon’s major misstep shows that drug pricing debate is here to stay

February 14, 2017
Manufacturing and Production, Sales and Marketing Duchenne Muscular Dystrophy, Emflaza, marathon

Marathon Pharmaceuticals’ approval, last week, by the FDA for its treatment for Duchenne muscular dystrophy would usually have been cause …

News
allergan

Allergan set to bolster ‘medical aesthetics’ unit with $2.5 billion Zeltiq deal

February 13, 2017
Manufacturing and Production, Sales and Marketing Allergan, FDA, Zeltiq

Allergan, the owner of Botox, has expanded its stake in the ‘medical aesthetics’ business by acquiring Zeltiq Aesthetics. Zeltiq has …

News

Pfizer and Flynn: How are ‘excessive’ prices for generic drugs possible and should competition authorities do more about exploitative pricing?

February 13, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Drug pricing, Pfizer, flynn

As last year came to a close, the headlines were rocked by the news that pharma giant Pfizer had been …

Feature

NICE turns down AZ’s chronic obstructive pulmonary disease drug

February 13, 2017
Sales and Marketing AstraZeneca, Daxas, NICE, chronic obstructive pulmonary disease

AstraZeneca’s Daxas (roflumilast) has been knocked back in draft guidance by the National Institute for Health and Care Excellence (NICE), …

News
headquarters_2_web

Lilly €200m expansion of Cork site under review

February 13, 2017
Manufacturing and Production, Sales and Marketing Eli Lilly, Ireland, cork

Eli Lilly’s planned €200m investment to its manufacturing plant in Kindsdale, County Cork, is now under-review. The expansion would bring …

News
ipsen_small

Ipsen to acquire Sanofi assets in $88 million deal

February 13, 2017
Sales and Marketing Boehringer Ingelheim, Prontalgine, Sanofi, ipsen

Ipsen has announced that it is set to enter into a definitive agreement to acquire five consumer healthcare products from …

News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026